The Use of Melatonin for Delirium Prevention in Medically Hospitalized Patients
Recruiting
Phase 2
Phase 3
Interventional Study
Delirium
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 65 and older
- Sex
- Any
- Trial phase
- Phase 2/3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 240 (estimated)
- Sponsor
- Sultan Qaboos University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The high prevalence of delirium in hospitalized older adults, with significant associated morbidity and mortality, emphasize the need for effective prevention strategies. Limited trials have explored melatonin's potential in preventing delirium among patients admitted to general medical wards. Previous trials on melatonin's preventive role in medical wards had limitations, necessitating a robust, …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patient aged 65 years and above acutely admitted under the care of General Internal Medicine Unit
Exclusion Criteria:
* Patients admitted to the ward, however meeting requirement for vasopressors or non-invasive ventilation.
* Patient admitted through emergency to Intensive …
Contacts